These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 13168107)

  • 1. [Studies on anti-influenzal vaccination. II. Comparison of immunization response to intradermal vaccination with a single and double dose].
    GIORDANO G; PINO G
    Riv Ist Sieroter Ital; 1953; 28(6):501-9. PubMed ID: 13168107
    [No Abstract]   [Full Text] [Related]  

  • 2. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the effectiveness of living anti-influenzal vaccine in the interepidemic period].
    Ginzburg LIa; Rubinshteĭn GG; Zhuk AS; Shulichenko AI; Ukazov IV; Dromashko AS
    Vrach Delo; 1966 Sep; 9():112-4. PubMed ID: 6001230
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
    J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of influenza by use of intradermal vaccination].
    Kyncl J
    Cas Lek Cesk; 2009; 148(5):191-3. PubMed ID: 19642311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New possibilities of active immunization against influenza].
    PATOCKA F; SLONIM D
    Prakt Lek; 1954 Oct; 34(20):463-5. PubMed ID: 13236838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Depot vaccines. II. Method for estimation of virus content in exstirpated deposits of PR-8-influenza virus-gamma-aluminum oxide vaccines].
    DRESCHER J
    Zentralbl Bakteriol Orig; 1957 Apr; 168(3-4):181-93. PubMed ID: 13434362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of nonspecific stimuli in immunizing effectiveness of living influenzal vaccine].
    BELKINA AI
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Sep; 9():33-7. PubMed ID: 13227507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Investigation on vaccination against influenza. I. Relation of immunitary response to intradermal and subcutaneous vaccinations].
    GIORDANO G; PINO G
    Riv Ist Sieroter Ital; 1953; 28(5):436-43. PubMed ID: 13135292
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of trial vaccination against influenza in the winter of 1952-53].
    VERLINDE JD; MAKSTENIEKS O
    Ned Tijdschr Geneeskd; 1954 Feb; 98(9):559-65. PubMed ID: 13154479
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
    J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P; Kositanont U; Sornsathapornkul P; Tothong P; Kanyok R; Thongcharoen P
    Vaccine; 2007 Jan; 25(4):659-63. PubMed ID: 17011678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
    Beyer WE; Palache AM; Lüchters G; Nauta J; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):125-32. PubMed ID: 15163500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of influenza immunization for inner-city children aged 6 to 23 months.
    Zimmerman RK; Hoberman A; Nowalk MP; Lin CJ; Greenberg DP; Weinberg ST; Bemm CW; Block B
    Am J Prev Med; 2004 Dec; 27(5):397-403. PubMed ID: 15556740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible.
    Gelinck LB; van den Bemt BJ; Marijt WA; van der Bijl AE; Visser LG; Cats HA; Rimmelzwaan GF; Kroon FP
    Vaccine; 2009 Apr; 27(18):2469-74. PubMed ID: 19368788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS; Peiris JS; Chan KH; Wong WH; Lau YL
    Pediatrics; 2007 Jun; 119(6):1076-82. PubMed ID: 17545373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults.
    Guthrie T; Hobbs CG; Davenport V; Horton RE; Heyderman RS; Williams NA
    J Infect Dis; 2004 Dec; 190(11):1927-35. PubMed ID: 15529256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.